TY - JOUR
T1 - Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice
AU - Wlodarczyk, Bogdan J.
AU - Ogle, Krystal
AU - Lin, Linda Ying
AU - Bialer, Meir
AU - Finnell, Richard H.
N1 - Publisher Copyright:
© 2015 John Wiley & Sons A/S.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Objectives: Based on the recent findings from animal studies, it has been proposed that the therapeutic use of valnoctamide, an anxiolytic drug developed in the early 1960s, be extended to treat other neurological disorders such as epilepsy and bipolar disease. Given the scarcity of adequate data on its prenatal toxicity, a comparative teratogenicity study of valnoctamide and two of the most commonly used drugs to treat bipolar disorder, risperidone and olanzapine, was carried out in a mouse model system. Methods: Pregnant dams were treated with the aforementioned three drugs at the dose levels calculated as an equal proportion of the respective LD50 values of these drugs. The main reproductive indices examined included the numbers of implantations and resorptions, viable and dead fetuses, and fetal gross, visceral and skeletal abnormalities. Results: The outcomes of the present study indicated that olanzapine was the most teratogenic of the three drugs, inducing maternal-, embryo-, and fetotoxicity. Risperidone also exerted a significant prenatal toxicity, but its adverse effect was less pronounced than that induced by olanzapine. Valnoctamide did not show any teratogenic effect, even when used in relatively higher dosages than olanzapine and risperidone. The observed increased skeletal abnormalities in one of the valnoctamide treatment groups were nonspecific and, as such, signaled a modest developmental delay rather than an indication that the compound could induce structural malformations. Conclusions: Under our experimental conditions, valnoctamide demonstrated the lowest prenatal toxicity of the three tested drugs.
AB - Objectives: Based on the recent findings from animal studies, it has been proposed that the therapeutic use of valnoctamide, an anxiolytic drug developed in the early 1960s, be extended to treat other neurological disorders such as epilepsy and bipolar disease. Given the scarcity of adequate data on its prenatal toxicity, a comparative teratogenicity study of valnoctamide and two of the most commonly used drugs to treat bipolar disorder, risperidone and olanzapine, was carried out in a mouse model system. Methods: Pregnant dams were treated with the aforementioned three drugs at the dose levels calculated as an equal proportion of the respective LD50 values of these drugs. The main reproductive indices examined included the numbers of implantations and resorptions, viable and dead fetuses, and fetal gross, visceral and skeletal abnormalities. Results: The outcomes of the present study indicated that olanzapine was the most teratogenic of the three drugs, inducing maternal-, embryo-, and fetotoxicity. Risperidone also exerted a significant prenatal toxicity, but its adverse effect was less pronounced than that induced by olanzapine. Valnoctamide did not show any teratogenic effect, even when used in relatively higher dosages than olanzapine and risperidone. The observed increased skeletal abnormalities in one of the valnoctamide treatment groups were nonspecific and, as such, signaled a modest developmental delay rather than an indication that the compound could induce structural malformations. Conclusions: Under our experimental conditions, valnoctamide demonstrated the lowest prenatal toxicity of the three tested drugs.
KW - Comparative teratogenicity
KW - Mice
KW - Olanzapine
KW - Risperidone
KW - Valnoctamide
UR - http://www.scopus.com/inward/record.url?scp=84941022498&partnerID=8YFLogxK
U2 - 10.1111/bdi.12325
DO - 10.1111/bdi.12325
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26292082
AN - SCOPUS:84941022498
SN - 1398-5647
VL - 17
SP - 615
EP - 625
JO - Bipolar Disorders
JF - Bipolar Disorders
IS - 6
ER -